Zobrazeno 1 - 10
of 981
pro vyhledávání: '"CLAUDIO COBELLI"'
Autor:
Alberto Dalla Libera, Chiara Toffanin, Martina Drecogna, Alfonso Galderisi, Gianluigi Pillonetto, Claudio Cobelli
Publikováno v:
APL Bioengineering, Vol 7, Iss 2, Pp 026105-026105-10 (2023)
Type 1 diabetes (T1D) is a chronic autoimmune disease featured by the loss of beta cell function and the need for lifetime insulin replacement. Over the recent decade, the use of automated insulin delivery systems (AID) has shifted the paradigm of tr
Externí odkaz:
https://doaj.org/article/77f2e9b28a604d59bf25427b58b306e9
Autor:
Marcello C. Laurenti, Praveer Arora, Chiara Dalla Man, James C. Andrews, Robert A. Rizza, Aleksey Matveyenko, Kent R. Bailey, Claudio Cobelli, Adrian Vella
Publikováno v:
Physiological Reports, Vol 10, Iss 13, Pp n/a-n/a (2022)
Abstract Abnormal postprandial suppression of glucagon in Type 2 diabetes (T2DM) has been attributed to impaired insulin secretion. Prior work suggests that insulin and glucagon show an inverse coordinated relationship. However, dysregulation of α
Externí odkaz:
https://doaj.org/article/47de651730664b97a1c702f3f237b300
Autor:
Giuseppe Fico, Liss Hernanzez, Jorge Cancela, Arianna Dagliati, Lucia Sacchi, Antonio Martinez-Millana, Jorge Posada, Lidia Manero, Jose Verdú, Andrea Facchinetti, Manuel Ottaviano, Konstantia Zarkogianni, Konstantina Nikita, Leif Groop, Rafael Gabriel-Sanchez, Luca Chiovato, Vicente Traver, Juan Francisco Merino-Torres, Claudio Cobelli, Riccardo Bellazzi, Maria Teresa Arredondo
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-16 (2019)
Abstract Background To understand user needs, system requirements and organizational conditions towards successful design and adoption of Clinical Decision Support Systems for Type 2 Diabetes (T2D) care built on top of computerized risk models. Metho
Externí odkaz:
https://doaj.org/article/d5717cd38eba4b43b06e21eec3b3bfdb
Autor:
Sudha S. Shankar, Douglas S. Lee, Ralph H. Raymond, Roberto A. Calle, Claudio Cobelli, Atalanta Ghosh, R. Paul Robertson, Hartmut Ruetten, Myrlene A. Staten, Darko Stefanovski, Adrian Vella, Sanya Whitaker, David A. Fryburg
Publikováno v:
Contemporary Clinical Trials Communications, Vol 10, Iss , Pp 94-99 (2018)
Standard practice to minimize variability in beta cell function (BCF) measurement is to test in inpatient (IP) settings. IP testing strains trial subjects, investigators, and budgets. Outpatient (OP) testing may be a solution although there are few r
Externí odkaz:
https://doaj.org/article/93654348a84b46b193cff126cf88a764
Publikováno v:
Metabolites, Vol 11, Iss 9, p 600 (2021)
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration through the subcutaneous (SC) tissue. Despite recent advances in insulin formulations, the SC route still suffers from delays and large inter/intra-s
Externí odkaz:
https://doaj.org/article/73f822cc8b744648ab07d1246c499b3d
Autor:
Adam R. Konopka, Raul Ruiz Esponda, Matthew M. Robinson, Matthew L. Johnson, Rickey E. Carter, Michele Schiavon, Claudio Cobelli, Fredric E. Wondisford, Ian R. Lanza, K. Sreekumaran Nair
Publikováno v:
Cell Reports, Vol 15, Iss 7, Pp 1394-1400 (2016)
Summary: The therapeutic mechanism of metformin action remains incompletely understood. Whether metformin inhibits glucagon-stimulated endogenous glucose production (EGP), as in preclinical studies, is unclear in humans. To test this hypothesis, we s
Externí odkaz:
https://doaj.org/article/3a0445036a964a44b608147e0fc0b1cc
Autor:
Claudio Cobelli, Andreas Caduff, Martin Mueller, Mark S. Talary, Giovanni Sparacino, Andrea Facchinetti, Mattia Zanon
Publikováno v:
Sensors, Vol 13, Iss 6, Pp 7279-7295 (2013)
In diabetes research, non-invasive continuous glucose monitoring (NI-CGM) devices represent a new and appealing frontier. In the last years, some multi-sensor devices for NI-CGM have been proposed, which exploit several sensors measuring phenomena of
Externí odkaz:
https://doaj.org/article/da4a25a7eb544078ad647e09cf3a6e3d
Autor:
Claudio Cobelli, Alberto Maran, Chiara Zecchin, Andrea Facchinetti, Mattia Zanon, Giovanni Sparacino
Publikováno v:
Sensors, Vol 12, Iss 10, Pp 13753-13780 (2012)
Monitoring glucose concentration in the blood is essential in the therapy of diabetes, a pathology which affects about 350 million people around the World (three million in Italy), causes more than four million deaths per year and consumes a signific
Externí odkaz:
https://doaj.org/article/3f4e2095d6e548eea3704c577b0f2f8c
Publikováno v:
Sensors, Vol 10, Iss 7, Pp 6751-6772 (2010)
The availability of continuous glucose monitoring (CGM) sensors allows development of new strategies for the treatment of diabetes. In particular, from an on-line perspective, CGM sensors can become “smart” by providing them with algorithms able
Externí odkaz:
https://doaj.org/article/9cf5bb090fc4437990da6cad41be3f6d
Autor:
Annamaria Guiotto, Zimi Sawacha, Alessandra Scarton, Gabriella Guarneri, Angelo Avogaro, Claudio Cobelli
Publikováno v:
Journal of Foot and Ankle Research, Vol 7, Iss S1, Pp n/a-n/a (2014)
Externí odkaz:
https://doaj.org/article/857c08696a9644109622f61e5f5dca5a